Mandate

Vinge advised Investindustrial on its acquisition of Carl von Linnékliniken Group.

Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.

Investindustrial Growth Holdings S.à r.l. is an investment group with €11 billion of raised fund capital and focuses on taking control positions in medium-sized companies in Europe.

Vinge’s team consisted of responsible partner Matthias Pannier and associates Stina Bengtsson, Olivia Belding (M&A), Christoffer Nordin (Regulatory), Sofia Bergenstråhle (Intellectual Property), Veronika Garemark (Employment), Karl-Hugo Engdahl (GDPR) and Nathalie Hughes (Project Assistance).

 

Related

Vinge advises Qben Infra in connection with issuance of senior, unsecured bonds and early redemption

Vinge has advised Qben Infra AB in connection with its issuance of senior, unsecured bonds in an amount of SEK 500,000,000 (within a framework of SEK 600,000,000) and the parallel early redemption by its subsidiary ININ Group AS in respect of its previously issued senior secured bonds due 2027.
January 16, 2025

Vinge advises Intera Partners in connection with the investment in Yellow Elk

Vinge has advised the Nordic private equity firm Intera Partners in connection with its investment in the AI and data analytics firm Yellow Elk.
January 15, 2025

Vinge has represented Inflexion in connection with the acquisition of Mecenat

Vinge has represented Inflexion in connection with the acquisition of the Mecenat group from IK. The acquisition of Mecenat is the first investment made through Inflexion's new Enterprise Fund VI, and Inflexion's first acquisition in Sweden.
January 14, 2025